BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 4603181)

  • 1. [A new antidepressive agent: C 34,276-Ba or maprotyline, 1st tetracyclic thymoanaleptic. Clinical study].
    Nieto Gómez D; Pérez Rincón H
    Prensa Med Mex; 1973; 38(11):429-34. PubMed ID: 4603181
    [No Abstract]   [Full Text] [Related]  

  • 2. A double-blind, comparative clinical trial with ludiomil (CIBA 34,276-Ba) and amitriptyline in newly admitted depressed patients.
    Amin M; Brahm E; Bronheim LA; Klingner A; Ban TA; Lehmann HE
    Curr Ther Res Clin Exp; 1973 Oct; 15(10):691-9. PubMed ID: 4201313
    [No Abstract]   [Full Text] [Related]  

  • 3. [Results of the clinical testing of amitriptylin and C 34,276-Ba (dibenzobicyclooctadiene derivative) in a double-blind study].
    Bruck J; Söllner E; Tschabitscher H
    Nervenarzt; 1974 Sep; 45(9):492-6. PubMed ID: 4612394
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical experiences with the new antidepressive agent Maprotilin 34'276 Ba].
    Floru L
    Med Welt; 1973 Aug; 24(33):1283-6. PubMed ID: 4764444
    [No Abstract]   [Full Text] [Related]  

  • 5. Maprotiline and amitriptyline in the treatment of depressive illness. A double-blind comparison.
    Levin A
    S Afr Med J; 1974 Jan; 48(2):47-9. PubMed ID: 4595136
    [No Abstract]   [Full Text] [Related]  

  • 6. WA 335 (danitracen): a preliminary evaluation of a potential antidepressant compound. A comparative double-blind study with WA 335 and amitriptyline in the treatment of depressive patients.
    Kaumeier S; Dohren J; Flach D
    Curr Ther Res Clin Exp; 1977 Jan; 21(1):108-13. PubMed ID: 401705
    [No Abstract]   [Full Text] [Related]  

  • 7. [Antidepressive medication and cardiovascular disorders: innocuity of clomipramine (Anafranil)].
    Delree G; Korn M; Lepkifker E; Bobon J
    Acta Psychiatr Belg; 1972 Sep; 72(5):602-12. PubMed ID: 4669432
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical experience with maprotyline in endogenous depression.
    Náhunek K; Kamenická V; Rodová A; Svestka J; Misurec J
    Act Nerv Super (Praha); 1973 May; 15(2):108-10. PubMed ID: 4752636
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical experience with melitracen in the treatment of depressive states].
    Brasseur R
    Schweiz Rundsch Med Prax; 1971 Feb; 60(8):249-53. PubMed ID: 5553886
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparative study of dibencycladine (Ludiomil) and imipramine in the treatment of psychotic depression].
    Roy JY; Pinard G; Hillel J; Gagnon MA; Tétreault L
    Int J Clin Pharmacol; 1973 Feb; 7(1):54-61. PubMed ID: 4699385
    [No Abstract]   [Full Text] [Related]  

  • 11. A controlled trial of maprotiline (Ludiomil) and amitriptyline in general practice.
    Kay NE; Davies B
    Med J Aust; 1974 May; 1(18):704-5. PubMed ID: 4603998
    [No Abstract]   [Full Text] [Related]  

  • 12. [Preliminary report on the terapeutic activity and clinical as well as biological tolerance of endovenous 34.276 Ba in melancholias and depressive conditions].
    Volmat R; Allers G; Vittouris N; Dufoy F
    Schweiz Arch Neurol Neurochir Psychiatr; 1973; 113(2):410-5. PubMed ID: 4776681
    [No Abstract]   [Full Text] [Related]  

  • 13. [Protriptylin in clinical and ambulatory use in various formes of depression].
    Plavec J; Steininger E
    Wien Med Wochenschr; 1968 Nov; 118(45):983-5. PubMed ID: 4884182
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical comparative evaluation of maprotiline, a new antidepressant drug. A multicentre study.
    Balestrieri A; Benassi P; Cassano GB; Castrogiovanni P; Catalano A; Colombi A; Conforto C; Del Soldato G; Giberti F; Lucchelli PE; Muratorio A; Nistri M; Sarteschi P
    Int Pharmacopsychiatry; 1971; 6(4):236-48. PubMed ID: 4950566
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical and EEG investigations with CI-579 and CI-600 (quantitative pharmacoelectroencephalography and "sleep prints").
    Itil TM; Saletu B; Gannon P; Arat M; Hsu W
    Behav Neuropsychiatry; 1973; 4-5(11-12, 1-6):61-8 passim. PubMed ID: 4583772
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of treatment with Melitracen (trausabun) in depressive states].
    Wojdyslawska I
    Psychiatr Pol; 1970; 4(4):449-53. PubMed ID: 5472582
    [No Abstract]   [Full Text] [Related]  

  • 17. [Single-blind comparative study between patients with ludiomil (Ciba 34,276-Ba) and its evaluation with Hamilton's scale].
    Rego A; Sanchez de Vega J
    Arch Neurobiol (Madr); 1974; 37(5):475-84. PubMed ID: 4615650
    [No Abstract]   [Full Text] [Related]  

  • 18. [Problems of differentiated thymoleptic therapy in phasic depressions].
    Smulevich AB; Vorob'ev VIu; Zavidovskaia GI; Lobova EK; Balashova MG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1974; 74(6):912-8. PubMed ID: 4454918
    [No Abstract]   [Full Text] [Related]  

  • 19. [New drug for the treatment of depressive syndromes].
    Fiume S
    Clin Ter; 1972 Aug; 62(4):367-76. PubMed ID: 4638878
    [No Abstract]   [Full Text] [Related]  

  • 20. Proceedings: Behavioral effects of maprotyline (Ciba 34, 276-Ba), a new antidepressant.
    Ueki S; Fujiwara M; Inoue K
    Jpn J Pharmacol; 1974; 24(0):s:55. PubMed ID: 4545609
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.